Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “multiple sclerosis”
- Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a Myelin Repair TherapyNot Yet Recruiting
Sponsor: University of California, San Francisco
Demyelinating Diseases · Demyelination; Corpus Callosum · Multiple Sclerosis Brain Lesion · Multiple Sclerosis Acute and Progressive
United States
- Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)Recruiting
Sponsor: University of California, San Francisco
Optic Neuritis
United States
Sponsor: VA Office of Research and Development
Multiple Sclerosis
United States
Sponsor: Lille Catholic University
Multiple Sclerosis
France
- Mechanisms of Disease Severity in Multiple Sclerosis: an Integrative Multimodal StudyActive Not Recruiting
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France
Multiple Sclerosis
France
- Neuroprotection With N-acetyl Cysteine for Patients With Progressive Multiple SclerosisActive Not Recruiting
Sponsor: Emmanuelle Waubant, MD PhD
Multiple Sclerosis · Multiple Sclerosis, Primary Progressive · Multiple Sclerosis, Secondary Progressive
United States
- DreaMS - Validation Study 1Active Not Recruiting
Sponsor: Research Center for Clinical Neuroimmunology and Neuroscience Basel
Multiple Sclerosis
Switzerland
- Validity and Reliability of Timed Up and Go Test in Dual-Task Conditions for Multiple Sclerosis PatientsEnrolling By Invitation
Sponsor: Sanko University
Multiple Sclerosis · Reliability and Validity · Dual Task
Turkey (Türkiye)
Sponsor: University of Calgary
Lower Limb; Sprain (Strain) · Lower Limb Fracture · Stroke · Multiple Sclerosis
Canada
Sponsor: State University of New York at Buffalo
Primary Progressive Multiple Sclerosis
United States
- Metaverse Applications in Clinical Neurorehabiliation: Device FeasibilityActive Not Recruiting
Sponsor: Istituto per la Ricerca e l'Innovazione Biomedica
Neurological Disorder · Multiple Sclerosis · Parkinson Disease · Stroke
Italy
Sponsor: University of Florida
Multiple Sclerosis (MS) - Relapsing-remitting · Upper Extremity Dysfunction
United States
Sponsor: Heinrich-Heine University, Duesseldorf
Multiple Sclerosis · Remitting-Relapsing Multiple Sclerosis · Primary Progressive Multiple Sclerosis · Secondary Progress Multiple Sclerosis
Germany
Sponsor: Assistance Publique - Hôpitaux de Paris
Multiple Sclerosis
France
- Evaluation of MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in Patients With ALSActive Not Recruiting
Sponsor: MediciNova
Amyotrophic Lateral Sclerosis
United States, Canada
Sponsor: Eli Lilly and Company
ALS (Amyotrophic Lateral Sclerosis)
Belgium, Canada, Germany, Netherlands, Spain
Sponsor: Assistance Publique - Hôpitaux de Paris
Children With Multiple Sclerosis
France
Sponsor: University Hospital, Basel, Switzerland
Multiple Sclerosis (MS)
Switzerland
- Hesperidin RCT in MSRecruiting
Sponsor: Swansea University
Multiple Sclerosis
United Kingdom
Sponsor: Cairo University
Multiple Sclerosis
Egypt
Sponsor: Assistance Publique - Hôpitaux de Paris
Overactive Bladder
France
Sponsor: PRG Science & Technology Co., Ltd.
Amyotrophic Lateral Sclerosis
United States
Sponsor: University of Edinburgh
Motor Neuron Disease, Amyotrophic Lateral Sclerosis
United Kingdom
- Exercise With and Without Cognitive TrainingNot Yet Recruiting
Sponsor: VA Office of Research and Development
Multiple Sclerosis
United States
Sponsor: Novartis Pharmaceuticals
Multiple Sclerosis
France, Germany, Italy, Spain